Switch theme
Sign up to access all valuation multiples
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
2010
159
LTM Revenue $4.8M
LTM EBITDA -$181M
$118M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cibus has a last 12-month revenue (LTM) of $4.8M and a last 12-month EBITDA of -$181M.
In the most recent fiscal year, Cibus achieved revenue of $4.3M and an EBITDA of -$242M.
Cibus expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cibus valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $4.8M | XXX | $4.3M | XXX | XXX | XXX |
| Gross Profit | $4.7M | XXX | $4.3M | XXX | XXX | XXX |
| Gross Margin | 99% | XXX | 100% | XXX | XXX | XXX |
| EBITDA | -$181M | XXX | -$242M | XXX | XXX | XXX |
| EBITDA Margin | -3800% | XXX | -5670% | XXX | XXX | XXX |
| EBIT | -$163M | XXX | -$77.0M | XXX | XXX | XXX |
| EBIT Margin | -3415% | XXX | -1806% | XXX | XXX | XXX |
| Net Profit | -$189M | XXX | -$251M | XXX | XXX | XXX |
| Net Margin | -3959% | XXX | -5898% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cibus's stock price is $3.
Cibus has current market cap of $106M, and EV of $118M.
See Cibus trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $118M | $106M | XXX | XXX | XXX | XXX | $-7.43 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cibus has market cap of $106M and EV of $118M.
Cibus's trades at 27.6x EV/Revenue multiple, and -0.5x EV/EBITDA.
Equity research analysts estimate Cibus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cibus has a P/E ratio of -0.6x.
See valuation multiples for Cibus and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $106M | XXX | $106M | XXX | XXX | XXX |
| EV (current) | $118M | XXX | $118M | XXX | XXX | XXX |
| EV/Revenue | 24.6x | XXX | 27.6x | XXX | XXX | XXX |
| EV/EBITDA | -0.6x | XXX | -0.5x | XXX | XXX | XXX |
| EV/EBIT | -0.7x | XXX | -1.5x | XXX | XXX | XXX |
| EV/Gross Profit | 25.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | -0.6x | XXX | -0.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -2.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCibus's last 12 month revenue growth is 48%
Cibus's revenue per employee in the last FY averaged $27K, while opex per employee averaged $0.5M for the same period.
Cibus's rule of 40 is -17237% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cibus's rule of X is -3681% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cibus and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 48% | XXX | 47% | XXX | XXX | XXX |
| EBITDA Margin | -3800% | XXX | -5670% | XXX | XXX | XXX |
| EBITDA Growth | -58% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -17237% | XXX | -5622% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -3681% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $27K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 1183% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 1906% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Hydratec Industries | XXX | XXX | XXX | XXX | XXX | XXX |
| Brazil Potash | XXX | XXX | XXX | XXX | XXX | XXX |
| House of Agriculture | XXX | XXX | XXX | XXX | XXX | XXX |
| Gujarat State Fertilizers & Chemicals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cibus acquired XXX companies to date.
Last acquisition by Cibus was XXXXXXXX, XXXXX XXXXX XXXXXX . Cibus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cibus founded? | Cibus was founded in 2010. |
| Where is Cibus headquartered? | Cibus is headquartered in United States of America. |
| How many employees does Cibus have? | As of today, Cibus has 159 employees. |
| Who is the CEO of Cibus? | Cibus's CEO is Dr. Peter Beetham, PhD. |
| Is Cibus publicy listed? | Yes, Cibus is a public company listed on NAS. |
| What is the stock symbol of Cibus? | Cibus trades under CBUS ticker. |
| When did Cibus go public? | Cibus went public in 2017. |
| Who are competitors of Cibus? | Similar companies to Cibus include e.g. Fertiglobe, Hydratec Industries, Brazil Potash, House of Agriculture. |
| What is the current market cap of Cibus? | Cibus's current market cap is $106M |
| What is the current revenue of Cibus? | Cibus's last 12 months revenue is $4.8M. |
| What is the current revenue growth of Cibus? | Cibus revenue growth (NTM/LTM) is 48%. |
| What is the current EV/Revenue multiple of Cibus? | Current revenue multiple of Cibus is 24.6x. |
| Is Cibus profitable? | Yes, Cibus is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cibus? | Cibus's last 12 months EBITDA is -$181M. |
| What is Cibus's EBITDA margin? | Cibus's last 12 months EBITDA margin is -3800%. |
| What is the current EV/EBITDA multiple of Cibus? | Current EBITDA multiple of Cibus is -0.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
